President Trump looking to get rid of bureaucratic red tape when authorizing vaccines, therapeutics

Health and Human Services Secretary Alex Azar speaks during a media briefing in the James Brady Briefing Room of the White House, Sunday, Aug. 23, 2020, in Washington.(AP Photo/Alex Brandon)

OAN Newsroom
UPDATED 10:53 AM PT – Wednesday, August 26, 2020

Department of Health & Human Services Secretary Alex Azar dismissed claims by certain media outlets that President Trump pressured the FDA into approving convalescent plasm” as a coronavirus treatment.

During an interview Wednesday, Azar said the process to get its approval was well underway before the president made the big announcement Sunday. He also noted that “speed matters” and said the U.S. is using the proper channels to ensure any virus cure or vaccine is safe.

“We have got move as quickly as possible, our normal timelines just can’t hold,” Azar explained. “We’ve got to move fast, the president insists on that, but we’re also going to insist that products whether therapeutics or vaccines meet the FDA’s standards of data and evidence to meet the regulatory requirement.”

The HHS secretary said the Trump administration has been working to ensure the U.S. limits the “unnecessary bureaucratic” barriers, which “stand in the way of saving lives.”

RELATED: Randomized plasma trials is silly talking point, says Navarro

Source link

Amber Coakley
Author: Amber Coakley

Be the first to comment

Leave a Reply

Your email address will not be published.